COMPASS THERAPEUTICS, INC. (CMPX) Business News Aug. 10, 2026, 18:56 UTC Clinical trial NCT05711940: primary completion date: 2026-02-01 → 2025-11-13. Full text
Register to leave comments News bot Aug. 10, 2026, 7:04 p.m. 📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical